Search Results 1861-1870 of 14756 for anti-TNF drugs
... treatment gaps of more than 12 weeks [84 days] between any two doses). Current Anti-Asthma Therapy: Asthma is currently being treated with a controller ...
The purpose of the study is to determine the extent of donor site morbidity after harvesting the medial femoral condyle for scaphoid nonunion treatment. The ...
About this study. CSM (Cervical spondylotic myelopathy) is the most common cause of spinal cord injury worldwide. While there is evidence from the recently ...
Use of an investigational anti-cancer drug within 28 days preceding the first dose of dabrafenib; Patients receiving any medications or substances that are ...
Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema. Study offers further evidence of a relatively safe systemic risk profile ...
Side Effects. Drug information provided by: Merative, Micromedex®. In 1976, a number of people who received the “swine flu” influenza vaccine developed ...
Treatment with another anti-amyloid investigational drug or other intervention within 12 months. Enrolled in another interventional clinical trial within ...
Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Sclerosol Intrapleural; Steritalc. Descriptions.
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your progress at regular visits to make sure ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.